• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Is evaluation of hepatitis a immunity required or not?是否需要评估甲型肝炎免疫力?
Hepat Mon. 2011 Dec;11(12):955-7. doi: 10.5812/kowsar.1735143X.764. Epub 2011 Dec 20.
2
Hepatitis A vaccine should receive priority in National Immunization Schedule in India.在印度,甲肝疫苗应作为国家免疫计划的优先疫苗。
Hum Vaccin Immunother. 2012 Aug;8(8):1132-4. doi: 10.4161/hv.20475. Epub 2012 Aug 1.
3
[Viral hepatitis A: when a changing epidemiology implies a different prophylaxis].甲型病毒性肝炎:不断变化的流行病学意味着不同的预防措施
Sante. 1998 Mar-Apr;8(2):113-7.
4
[Vaccination against hepatitis A].[甲型肝炎疫苗接种]
Pediatr Med Chir. 1996 May-Jun;18(3):259-62.
5
Hepatitis A: epidemiology in resource-poor countries.甲型肝炎:资源匮乏国家的流行病学
Curr Opin Infect Dis. 2015 Oct;28(5):488-96. doi: 10.1097/QCO.0000000000000188.
6
Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.孟买甲型肝炎病毒血清流行率及甲型肝炎疫苗的免疫原性和安全性。
Indian J Gastroenterol. 1998 Jan;17(1):16-8.
7
[Hepatitis A virus infection. A review].[甲型肝炎病毒感染。综述]
Praxis (Bern 1994). 2003 Oct 1;92(40):1659-73. doi: 10.1024/0369-8394.92.40.1659.
8
Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review.甲型肝炎病毒感染和人免疫缺陷病毒阳性患者的甲型肝炎疫苗接种:综述。
World J Gastroenterol. 2017 May 28;23(20):3589-3606. doi: 10.3748/wjg.v23.i20.3589.
9
Perspectives on the control of hepatitis A by vaccination.
Vaccine. 1992;10 Suppl 1:S93-6. doi: 10.1016/0264-410x(92)90555-x.
10
Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran.甲型肝炎病毒免疫:来自伊朗的全国性基于人群的血清流行率研究。
Vaccine. 2020 Oct 21;38(45):7100-7107. doi: 10.1016/j.vaccine.2020.08.071. Epub 2020 Sep 9.

引用本文的文献

1
Seroprevalence of hepatitis A virus among Iranian soldiers.伊朗士兵中甲肝病毒血清流行率。
Gastroenterol Hepatol Bed Bench. 2016 Spring;9(2):100-4.
2
Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers.甲型肝炎病毒感染、疫苗接种与伊朗医护人员
Hepat Mon. 2015 Dec 29;15(12):e35238. doi: 10.5812/hepatmon.35238. eCollection 2015 Dec.
3
Vaccination in Health Care Workers Should be Following in our Country Now?!我国现在是否应该推行医护人员接种疫苗?
Iran Red Crescent Med J. 2013 Dec;15(12):e17145. doi: 10.5812/ircmj.17145. Epub 2013 Dec 5.
4
Prevention of hepatitis a virus infection, need to vaccinate or not?预防甲型肝炎病毒感染,需要接种疫苗吗?
Int J Prev Med. 2013 Aug;4(8):863-5.

本文引用的文献

1
Seroepidemiology of hepatitis a in the croatian population.克罗地亚人群甲型肝炎的血清流行病学
Hepat Mon. 2011 Dec;11(12):997-9. doi: 10.5812/kowsar.1735143X.756. Epub 2011 Dec 20.
2
Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health.甲型肝炎病毒感染:它对公众健康构成重大危害吗?:甲型肝炎病毒对公众健康的危害
Hepat Mon. 2011 Apr;11(4):235-7.
3
Comparison of the prevalence of major transfusion-transmitted infections among Iranian blood donors using confidential unit exclusion in an Iranian population: Transfusion-transmitted infections among Iranian blood donors.在伊朗人群中使用保密单位排除法比较伊朗献血者中主要输血传播感染的流行率:伊朗献血者中的输血传播感染
Hepat Mon. 2011 Jan;11(1):11-3.
4
Challenges to mapping the health risk of hepatitis A virus infection.甲型肝炎病毒感染的健康风险映射面临的挑战。
Int J Health Geogr. 2011 Oct 18;10:57. doi: 10.1186/1476-072X-10-57.
5
Seroprevalence of hepatitis A immunity among brazilian adult patients with liver cirrhosis: is HAV vaccination necessary?巴西肝硬化成年患者甲型肝炎免疫的血清流行率:是否需要接种 HAV 疫苗?
Braz J Infect Dis. 2011 May-Jun;15(3):268-71. doi: 10.1016/s1413-8670(11)70187-8.
6
Seroepidemiology of hepatitis A in Korea: changes over the past 30 years.韩国甲型肝炎血清流行病学:过去 30 年的变化。
J Korean Med Sci. 2011 Jun;26(6):791-6. doi: 10.3346/jkms.2011.26.6.791. Epub 2011 May 18.
7
Clinical features of re-emerging hepatitis A: an analysis of patients hospitalized during an urban epidemic in Korea.再发性甲型肝炎的临床特征:韩国城市流行期间住院患者的分析。
Yonsei Med J. 2011 Jul;52(4):686-91. doi: 10.3349/ymj.2011.52.4.686.
8
Hepatitis A - prevention in travellers.甲型肝炎——旅行者的预防措施
Aust Fam Physician. 2010 Dec;39(12):924-8.
9
Decrease in seroprevalence of hepatitis A after the implementation of nationwide disposable tableware use in Taiwan.在台湾实施全国范围内使用一次性餐具后,甲型肝炎血清流行率下降。
BMC Public Health. 2010 Nov 23;10:719. doi: 10.1186/1471-2458-10-719.
10
Factors influencing the severity of acute viral hepatitis A.影响甲型急性病毒性肝炎严重程度的因素。
Korean J Hepatol. 2010 Sep;16(3):295-300. doi: 10.3350/kjhep.2010.16.3.295.

是否需要评估甲型肝炎免疫力?

Is evaluation of hepatitis a immunity required or not?

作者信息

Ghorbani Gholam Ali

机构信息

Department of Infectious Diseases, Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Tehran, IR Iran.

出版信息

Hepat Mon. 2011 Dec;11(12):955-7. doi: 10.5812/kowsar.1735143X.764. Epub 2011 Dec 20.

DOI:10.5812/kowsar.1735143X.764
PMID:22368677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3282026/
Abstract

Hepatitis A virus (HAV) infection is one of the most common causes of acute hepatitis and it is a serious health problem worldwide. HAV infection is a vaccine preventable disease that can produce the lifelong immunity seen in many developed countries with the vaccination schedule administered to children; however this vaccine is not used in developing countries at the present time. Improvements in food and water hygiene have caused a displacement of hepatitis A infection from children to adults which has increased mortality rates. Therefore evaluation of HAV immunity levels can help health authorities develop polices for prophylaxis especially in developing countries.

摘要

甲型肝炎病毒(HAV)感染是急性肝炎最常见的病因之一,也是全球范围内严重的健康问题。HAV感染是一种可通过疫苗预防的疾病,在许多发达国家,按照儿童疫苗接种计划接种疫苗后可产生终身免疫力;然而,目前发展中国家并未使用这种疫苗。食品和水卫生条件的改善导致甲型肝炎感染人群从儿童转向成人,这增加了死亡率。因此,评估HAV免疫水平有助于卫生当局制定预防政策,特别是在发展中国家。